Form 4 for CYTK CYTOKINETICS INC
Accepted 2023-08-21 00:00:00 ET · period of report 2023-08-21 · accession 0001127602-23-023012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-21 | 2023-08-21 | CYTK | WIERENGA WENDALL | Dir | S - Sale+OE | $32.02 | -6,020 | 18.2K | -25% | -$192.8K |
| D | 2023-08-21 | 2023-08-21 | CYTK | WIERENGA WENDALL | Dir | M - OptEx | $6.72 | +6,020 | 24.2K | +33% | +$40.5K |
| D | 2023-08-21 | 2023-08-21 | CYTK | WIERENGA WENDALL | Dir | M - OptEx | $0.00 | -6,020 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-21 | S | D | 6,020 | $32.02 | 18,205 | D | — | — | |
| 2 | Common | Common Stock | 2023-08-21 | M | A | 6,020 | $6.72 | 24,225 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2023-08-21 | M | D | 6,020 | $0.00 | 0 | D | $6.72 · 2014-02-02 to 2024-01-02 | 6,020 Common Stock |